article · Medicine
Managing human immunodeficiency virus (HIV) infection requires effective monitoring tools, yet traditional markers have limitations in capturing complex immune responses and inflammatory dynamics. Emerging approaches focus on inflammation ratios to better evaluate the interplay between immune function, inflammation, and HIV. Specific metrics, such as the CD4/CD8 ratio, the neutrophil-to-lymphocyte ratio, and the monocyte-to-lymphocyte ratio, provide a more comprehensive picture of a patient's immune and inflammatory condition. Integrating these ratios into regular care could help clinicians anticipate disease complications and tailor personalised treatment strategies. Ongoing research remains essential to refine the clinical understanding and practical value of these immunological markers to improve outcomes for people living with HIV.
Standard HIV monitoring tools can miss subtle shifts in immune health and chronic inflammation. Using simple cellular ratios derived from routine blood tests could give clinicians a clearer view of a patient's overall health, helping them detect complications earlier and tailor treatments more effectively to individual needs.
The work highlights clinical monitoring applications that could be used by healthcare providers and diagnostics developers to guide personalised HIV therapies. Because the abstract presents an overview of an emerging concept rather than a validated diagnostic product, the research appears to be at an early stage, requiring further clinical study before routine adoption.
AI-generated from the published abstract. Always read the original work before citing.
Human immunodeficiency virus (HIV) infection remains a significant global health concern, necessitating ongoing research and innovation in the quest for improved disease management. Traditional markers for monitoring HIV progression and the effectiveness of antiretroviral therapy have limitations in capturing the intricate immune responses and inflammatory dynamics in people with HIV. In recent years, the concept of inflammation ratios has gained prominence as a valuable tool for assessing and understanding the complex interplay between inflammation, immune function, and HIV. In this abstract, we provide an overview of the emerging field of utilizing inflammation ratios in the context of HIV and its implications for disease monitoring and therapeutic strategies. These ratios, such as the CD4/CD8 ratio, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio, offer a more comprehensive assessment of an individual's immune status and inflammatory state. By exploring the clinical implications of inflammation ratios, including their potential to predict disease complications and guide personalized treatment approaches, this publication sheds light on the potential benefits of incorporating inflammation ratios into routine HIV care. Furthermore, we emphasize the importance of ongoing research in this field to further refine our understanding of the utility and significance of inflammation ratios in improving the lives of people with HIV.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1097/md.0000000000037354
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
